The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
AliceBeagle3,
One of the few facts you’ll ever get on these boards is don’t listen to anyone (me included). These boards can help in as much as giving you a helpful pointer towards your own research, but that’s about it.
This share and it’s CEO has a tortuous past, but a future share price may or may not have anything to do with it’s past, there is loads of AIM shares that did nothing more than pay Executives and Dilute its shareholders for a decade or more, as Kibo has done and then one day went on a parabolic ballistic march northwards.
There is real hope for MAST, but Louis Coetzee has to do something he’s never done before and actually pull something across the line in terms of delivery.
Lastly, don’t pay any attention to me.
JD
https://www.lse.co.uk/rns/KIBO/settlement-and-termination-of-clns-and-placing-nng2p9r52qvfrev.html
RNS of 17 September.
JD
All the tweets across KIBO, KAT AND MAST have stopped and (again) all the time lines on Mast, Mozambique, Haneti and Blyvoor have gone out the window.
You try and be positive but **** me, there comes a point…
JD
To be fair, it could affect longs or shorts depending if anyone out there has long or short margin bets on Kibo with IG and this creates a “squeeze” on that position. Historically, on this share, I would tend to agree this would probably be a greater risk on the short side with Kibo as I can’t see many going long on Kibo with margin bets, correct me if I am wrong, anyone, however, there has been a history of undisclosed shorts here.
I doubt IG makes much money down this end of the markets, after what happened with Robin Hood and Gamestop, I doubt IG wants to be holding that mess should it happen here and is shutting down it’s retail operation.
https://mobile.twitter.com/mastplc
Been updated with Mast's LSE Ticker handle (MAST.L), hopefully FCA Approval Monday or Tuesday next week.
JD
10 business days for the FCA to respond and approve listing and then 5 to 10 business days after this to list (they already have the ticker from LSE so that part is obviously ready to go), I’ll say Monday 8th March listing, but should get FCA approval RNS very early next week.
PHE, AFC, EQT, all many, many multiples of MED, you have to think there will be a serious gap up on opening.
JD
More will get taken as the next couple of weeks unfold, they are at such bombed out rates I expect all the of the outstanding warrant will be taken in H1 2021. And will leave us with £5/6m of cash on the books which is approx. 2 years of cash to Kibo. For people buying in now or recently, well done, with no prospect of dilution via a chronic and desperate fundraising and with MAST listing only 2/3 weeks away you should do very well here, and I expect I may even get out of here with some profit myself!
Louis Coetzee doesn’t do good Comms or Presentations, this one is no different, it’s a lazily put together document with multiple things wrong with it, even the IPO numbers (stating the starting £20m MCAP and not the eventual £23m MCAP) are out of date, he couldn’t even be bothered to change the date on the presentation. But this was never for us, this was part of a larger document that was used to sell his IPO and has probably been touting it about for 2 / 3 months or so, we were just an afterthought.
It doesn’t matter though, as every company I have researched on LSE with comparable mega-wattage to MED and growth potential has an MCAP way above £23m, in some cases many multiples, and on opening I can’t see how this doesn’t fly? We just have to recognise that as part of this exercise we don’t really matter but can still make money from it…
It was pretty evident from the presentation that PI’s don’t really matter when it comes to MED (and I have no problem with that). 75% is locked up between Kibo and St An and the rest has been gobbled up by Institutional Investors. Come listing day with so little out there, and a clean start company on the LSE Main List I expect it to do wonderful things (and the rising tide will lift HMS Kibo).
That presentation looked like it was from last year when they were going round selling this to the Institutional Investors at an early stage, safe to say whomever put up £5.5m had a damn site better presentation than we just got!
Fun and games, they took it down to 0.4p but will now take an 8 figure sum of shares off you with no NT at the Bid Price and put up a ridiculous spread to discourage anyone from buying, make no doubt they are short…set up nicely.
When the wind turbines fail….your power goes out…
https://www.independent.co.uk/news/world/americas/frozen-wind-turbines-texas-power-outages-b1802596.html
JD
Agreed, SGB. Looking at our Peers, our MCAP is shot to bits in comparison in terms of assets / projects, the reason for that isn’t quality of projects or assets, it’s due to the share register and the market knowing only fine well that we need cash on a routine basis and never allowing the SP to recover no matter what the news. If this is taken out of the equation, watch the SP go!
JD